Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Disease response to the histone deacetylase inhibitor panobinostat in refractory hodgkin lymphoma

Dickinson M, Ritchie D, DeAngelo DJ, Bishton M, Spencer A, Fischer T, Bhalla KN, Giles FJ, Liu A, Parker K, Laird G, Masson E, Scott JW, Ottman OG, Prince HM. Disease response to the histone deacetylase inhibitor panobinostat in refractory hodgkin lymphoma. 2008; submitted.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.